captopril has been researched along with Cardiovascular Diseases in 77 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (10.39) | 18.7374 |
| 1990's | 22 (28.57) | 18.2507 |
| 2000's | 32 (41.56) | 29.6817 |
| 2010's | 13 (16.88) | 24.3611 |
| 2020's | 2 (2.60) | 2.80 |
| Authors | Studies |
|---|---|
| Kini, RM; Koh, CY | 1 |
| Bendeliani, NG; Gilyarevsky, SR; Golshmid, MV; Kuzmina, IM; Sinitcina, II; Zaharova, GY | 1 |
| Hayashi, R; Kitamura, T; Mukai, K; Murata, M; Otsuki, M; Shimomura, I; Tamada, D | 1 |
| de Nucci, G; Dicay, M; MacNaughton, WK; Vaughan, D; Wallace, JL | 1 |
| Cheng, B; Cui, T; Fu, XB; Li, SH; Liao, X; Liu, HW; Xiao, J; Xiao, LL | 1 |
| Cabrera, AG; Ghazi, P; Moffett, BS | 1 |
| Helal, F; Lane, ME | 1 |
| Chen, B; Wu, QN; Zhang, JX; Zhang, YP | 1 |
| Borghi, C; Omboni, S | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 1 |
| Balasingam, M; George, K; Kantor, PF; Manlhiot, C; McCrindle, BW; Roche, SL; Timberlake, K; Wilson, J | 1 |
| Antunes, AM; Ávila, JP; Fierro, IM; Guerrante, RD; Lins Mendes, FM | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D; Omboni, S; Reggiardo, G | 1 |
| Cameron, A; Ewen, M; Laing, RO; van Mourik, MS | 1 |
| Burnier, M; Martin, PY | 1 |
| Bicket, DP | 1 |
| Eguchi, K; Kario, K; Shimada, K | 1 |
| Dierkes, J; Luley, C; Rading, A; Westphal, S | 1 |
| Bennett, HA; Bonari, L; Einarson, TR; Han, D; Hemels, ME; Traverso, ML | 1 |
| Krantz, MJ | 1 |
| Califf, RM; Edwards, S; Henis, M; Køber, L; Leimberger, JD; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Sellers, MA; Solomon, SD; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, H; Zelenkofske, S | 1 |
| Liebson, PR | 1 |
| Bernstein, V; Braunwald, E; Brown, EJ; Dagenais, GR; Davis, BR; Gordon, D; Kenchaiah, S; Lamas, GA; Pfeffer, MA; Rouleau, JL; Steingart, RM; Sussex, B | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Anavekar, NS; Califf, RM; Dickstein, K; Kober, L; Leimberger, JD; Maggioni, A; McMurray, JJ; Nordlander, R; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, EJ; White, HD; Zelenkofske, S | 1 |
| Higashiura, K; Shimamoto, K; Yoshida, D | 1 |
| Aylward, PE; Barvik, S; Califf, RM; Dalby, AJ; Huang, Z; Marin-Neto, JA; McMurray, JJ; Murin, J; Nordlander, RO; Pfeffer, MA; van Gilst, WH; Weaver, WD; White, HD; Zannad, F | 1 |
| Borghi, C; Cosentino, E; De Sanctis, D | 1 |
| Califf, R; Howlett, J; Køber, L; Maggioni, A; McMurray, J; Pfeffer, M; Pieper, K; Reed, S; Rouleau, J; Solomon, S; Swedberg, K; Van de Werf, F; Velazquez, E; White, H | 1 |
| Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
| Ivleva, AIa | 1 |
| Borghi, C; Cicero, AF | 1 |
| Giliarevskiĭ, SR | 1 |
| Karnad, DR; Krishnan, A; Sonawane, RV | 1 |
| Califf, RM; Howlett, J; Kober, L; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Signorovitch, J; Solomon, SD; Thune, JJ; Velazquez, EJ; Zelenkofske, S | 1 |
| Anavekar, NS; Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, E; White, H | 1 |
| Abel, ED; Buchanan, J; Cooksey, RC; Tabbi-Anneni, I | 1 |
| Atlas, SA; Case, DB | 1 |
| Drayer, JI; Weber, MA | 1 |
| Zhukova, IM | 1 |
| Hansson, L | 1 |
| Mareev, VIu | 1 |
| Duda, SG; Filatova, NP; Metelitsa, VI; Mukhamedzhanova, GF; Ostrovskaia, TP; Vygodin, VA | 1 |
| Cooke, HM; De Besse, A | 1 |
| Al, MJ; Kingma, JH; Kragten, JA; Michel, BC; Remme, WJ; van Hout, BA; van Nieuwenhuizen, R | 1 |
| Basta, L; Braunwald, E; Flaker, GC; Gersh, BJ; Lamas, GA; Mitchell, GF; Moyé, L; Pfeffer, MA; Smith, SC | 1 |
| Berecek, KH; Bishop, SP; Regan, CP | 1 |
| Arnold, MO; Braunwald, E; Lamas, G; Moye, L; Parker, JO; Pfeffer, MA; Plappert, T; Rouleau, J; Rouleau, JL; St John Sutton, M; Sussex, B | 1 |
| Davis, BR; Hager, WD; Lamas, GA; Moye, LA; Pfeffer, MA; Riba, A; Rouleau, JL; Wun, CC | 1 |
| Krakoff, LR; Rajasekharaiah, V | 1 |
| Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Rady, MY; Ryan, T | 1 |
| Scheen, AJ | 1 |
| Grossman, E; Messerli, FH | 1 |
| Force, RW; Hachey, D | 1 |
| Gong, L; Liu, L; Staessen, JA; Wang, JG | 1 |
| Alderman, MH; Applegate, WB; Furberg, CD; Pahor, M; Psaty, BM; Williamson, JD | 1 |
| Coca, A; Ruilope, LM | 1 |
| Francis, GS; Gassler, JP | 1 |
| Birkenhäger, WH; Fagard, RH; Gong, L; Liu, L; Staessen, JA; Wang, JG | 1 |
| Hansson, L; Hedner, T; Lanke, J; Niklason, A; Niskanen, L | 1 |
| Larger, E; Marre, M | 1 |
| Hansson, L; Hildebrandt, PR; Kjeldsen, SE; Lund-Johansen, P; Tuxen, CD | 1 |
| Studney, D | 1 |
| Cheung, BM | 1 |
| Dahlöf, B; Hansson, L; Hedner, T | 1 |
| Basta, L; Braunwald, E; Brown, EJ; Cuddy, TE; Davis, BR; Flaker, GC; Geltman, EM; Goldman, S; Moyé, LA; Pfeffer, MA | 1 |
| Cohn, JN | 1 |
| Kyriakidis, CA; Kyriakidis, MK; Mavrikakis, ME; Psarros, TK; Sfikakis, PP; Toutouzas, PK; Vergos, CG; Vyssoulis, GP | 1 |
| Bühler, FR; Rett, K; Ritz, E | 1 |
| Fyhrquist, F | 1 |
| Cochat, P | 1 |
| Omae, T | 1 |
22 review(s) available for captopril and Cardiovascular Diseases
| Article | Year |
|---|---|
Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Cardiovascular Diseases; Drug Development; Humans; Peptides; Snake Venoms; Toxins, Biological | 2020 |
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Hydrogen Sulfide; Naproxen | 2018 |
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.
Topics: Animals; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Captopril; Cardiovascular Diseases; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Risk Factors | 2014 |
Case study of patents related to captopril, Squibb's first blockbuster.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Drug Design; Drug Industry; Humans; Hypertension; Patents as Topic | 2016 |
Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Control
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Captopril; Cardiomegaly; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetic Retinopathy; Humans; Hypertension; Irbesartan; Kidney Diseases; Losartan; Practice Guidelines as Topic; Risk; Tetrazoles | 2002 |
A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Heart; Humans; Hypertension; Myocardial Infarction | 2004 |
[Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Glucose Intolerance; Humans; Hypertension; Insulin Resistance; Life Style; Losartan; Nifedipine; Risk | 2005 |
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Captopril; Cardiovascular Diseases; Enalapril; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Ventricular Dysfunction | 2005 |
[Efficacy of a new ACE inhibitor zofenopril (zocardis) in cardiovascular diseases].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Humans; Treatment Outcome | 2006 |
Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Severity of Illness Index; Treatment Outcome | 2006 |
[Three lives of captopril in the era of evidence based medicine].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Evidence-Based Medicine; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Renin in essential hypertension.
Topics: Adrenergic beta-Antagonists; Age Factors; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Humans; Hypertension; Posture; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Saralasin; Sodium | 1981 |
[Use of captopril in cardiology practice].
Topics: Adult; Captopril; Cardiomyopathies; Cardiovascular Diseases; Child; Dinoprostone; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Proline; Prostaglandins E; Renal Artery Obstruction; Renin-Angiotensin System; Stimulation, Chemical | 1983 |
Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Renin-Angiotensin System | 1998 |
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Randomized Controlled Trials as Topic | 2000 |
[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Diseases; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Time Factors | 2000 |
[Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Nifedipine; Prospective Studies; Randomized Controlled Trials as Topic | 2001 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
Blockade of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Humans; Hypertension; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |
20 trial(s) available for captopril and Cardiovascular Diseases
| Article | Year |
|---|---|
Angiotensin-Converting Enzyme Inhibitor Initiation and Dose Uptitration in Children With Cardiovascular Disease: A Retrospective Review of Standard Clinical Practice and a Prospective Randomized Clinical Trial.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Cardiovascular Diseases; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Heart Failure; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Retrospective Studies; Time Factors; Ventricular Dysfunction | 2016 |
Antihypertensive treatment and homocysteine concentrations.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Cystatin C; Cystatins; Female; Folic Acid; Homocysteine; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Vitamin B 12; Vitamin B 6 | 2003 |
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survivors; Ventricular Dysfunction, Left | 2004 |
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Chronic Disease; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Survival Rate; Tetrazoles; Valine; Valsartan | 2004 |
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarct
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Captopril; Cardiovascular Diseases; Cause of Death; Heart Failure; Humans; Middle Aged; Morbidity; Mortality; Myocardial Infarction; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
Topics: Aged; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Diabetes Complications; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
The Captopril Prevention Project (CAPPP): description and status.
Topics: Antihypertensive Agents; Captopril; Cardiovascular Diseases; Double-Blind Method; Humans; Hypertension; Prospective Studies; Randomized Controlled Trials as Topic | 1994 |
[The basic antihypertensive drugs for the long-term secondary prevention of cardiovascular diseases (the working group of the multicenter study Captopril and the Quality of Life)].
Topics: Algorithms; Antihypertensive Agents; Azerbaijan; Captopril; Cardiovascular Diseases; Humans; Hypertension; Quality of Life; Risk Factors; Russia; Ukraine | 1994 |
Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Creatinine; Drug Interactions; Enalapril; Guidelines as Topic; Humans; Kidney; Kidney Diseases; Prospective Studies | 1994 |
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators.
Topics: Aged; Captopril; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Double-Blind Method; Female; Forecasting; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Infarction; Ventricular Function, Left | 1997 |
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
Topics: Captopril; Cardiovascular Diseases; Echocardiography; Forecasting; Humans; Myocardial Infarction; Survival Analysis; Time Factors; Ventricular Function, Left | 1997 |
[Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Mellitus; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 1999 |
Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Asian People; Blood Pressure; Captopril; Cardiovascular Diseases; China; Diabetes Complications; Female; Humans; Hydrochlorothiazide; Hypertension; Incidence; Male; Middle Aged; Nitrendipine; Prospective Studies; Risk Factors; Sex Factors; Smoking | 2000 |
Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; China; Creatinine; Diuretics; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Nitrendipine; Prognosis; Regression Analysis; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Uric Acid | 2001 |
Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Captopril; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetic Angiopathies; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk; Stroke | 2001 |
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
Topics: Adult; Captopril; Cardiomegaly; Cardiovascular Diseases; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Stroke Volume; Survival Rate; Ventricular Function, Left | 1992 |
The prevention of heart failure--a new agenda.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Follow-Up Studies; Heart Failure; Humans; Myocardial Infarction; Ventricular Function, Left | 1992 |
The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension. The CAPPP Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Captopril; Cardiovascular Diseases; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Survival Rate; Sweden | 1990 |
Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril.
Topics: Administration, Oral; Adult; Captopril; Cardiac Catheterization; Cardiovascular Diseases; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Prospective Studies; Scleroderma, Systemic; Vascular Resistance | 1991 |
35 other study(ies) available for captopril and Cardiovascular Diseases
| Article | Year |
|---|---|
[Evidence-Based Information Which Could Influence Arterial Hypertension Treatment Approach after Publication of SPRINT Trial Results].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Humans; Hypertension | 2020 |
Saline Infusion Test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism.
Topics: Aged; Captopril; Cardiovascular Diseases; Cerebrovascular Disorders; Diagnostic Tests, Routine; Female; Furosemide; Humans; Hyperaldosteronism; Incidence; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Assessment | 2017 |
Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Epidermal Cells; Humans; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Regeneration; Renin-Angiotensin System; Skin; STAT1 Transcription Factor; STAT3 Transcription Factor; Stem Cells; Wound Healing | 2019 |
Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients.
Topics: Acute Kidney Injury; Adolescent; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Creatinine; Enalapril; Female; Humans; Hypotension; Infant; Male; Retrospective Studies | 2014 |
Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antioxidants; Captopril; Cardiovascular Diseases; Mice; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Uric Acid | 2015 |
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left | 2016 |
Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
Topics: Antihypertensive Agents; Atenolol; Captopril; Cardiovascular Diseases; Cost of Illness; Developing Countries; Health Services Accessibility; Humans; Hydrochlorothiazide; Losartan; Nifedipine; World Health Organization | 2010 |
[Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Disease Progression; Dose-Response Relationship, Drug; Drug Combinations; Drug Delivery Systems; Drug Interactions; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System; Risk Assessment | 2012 |
HOPE study impact on ACE inhibitors use.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Canada; Captopril; Cardiovascular Diseases; Drug Utilization; Female; Humans; Logistic Models; Male; Ramipril; Time Factors | 2003 |
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Evidence-Based Medicine; Humans; Hypertension; Losartan; Risk Management; Treatment Outcome | 2003 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Captopril; Cardiovascular Diseases; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Valine; Valsartan | 2006 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
Captopril in the treatment of cardiovascular manifestations of indian red scorpion (Mesobuthus tamulus concanesis Pocock) envenomation.
Topics: Administration, Oral; Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiovascular Diseases; Humans; Middle Aged; Retrospective Studies; Scorpion Stings; Scorpions; Treatment Outcome | 2007 |
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Body Weight; Captopril; Cardiovascular Diseases; Drug Evaluation, Preclinical; Glucose; Heart; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardium; Obesity; Organ Culture Techniques; Organ Size; Oxygen Consumption; Signal Transduction | 2008 |
Severe hypertension: special problems in the elderly.
Topics: Acute Disease; Administration, Oral; Age Factors; Aged; Antihypertensive Agents; Blood Pressure; Brain Diseases; Captopril; Cardiovascular Diseases; Diuretics; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Middle Aged; Obesity; Patient Compliance | 1983 |
[Scientific symposium "Captopril in the Treatment of Cardiovascular Diseases"].
Topics: Asia, Central; Captopril; Cardiovascular Diseases; Humans | 1993 |
Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output, Low; Cardiovascular Diseases; Computer Simulation; Cost-Benefit Analysis; Drug Costs; Humans; Models, Theoretical; Mortality; Netherlands; Preventive Medicine; Ventricular Dysfunction, Left | 1996 |
Early, short-term treatment with captopril permanently attenuates cardiovascular changes in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Captopril; Cardiovascular Diseases; Coronary Vessels; Heart; Hypertension; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1997 |
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides | 1998 |
The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiopulmonary Bypass; Cardiovascular Diseases; Cardiovascular Surgical Procedures; Case-Control Studies; Electrocardiography; Enalapril; Female; Follow-Up Studies; Hospital Mortality; Humans; Incidence; Intra-Aortic Balloon Pumping; Lisinopril; Male; Middle Aged; Multiple Organ Failure; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
CAPPP trial. Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Humans; Hypertension | 1999 |
The effect of ACE inhibitors on cardiovascular morbidity and mortality.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Captopril; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results; Sodium Chloride Symporter Inhibitors | 1999 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
[Prediction, screening and treatment of renal complications of diabetes].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Primary Prevention; Prognosis; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Risk Factors; Time Factors | 2001 |
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point.
Topics: Blood Pressure; Captopril; Cardiovascular Diseases; Diuretics; Humans; Prospective Studies; Randomized Controlled Trials as Topic | 1992 |
[Comprehensive therapy of the cardiovascularly compromised patient. New risks--insulin resistance. Captopril as choice No. 1. Report from the 63rd scientific meeting of the American Heart Association. Dallas, 11 November 1990].
Topics: Captopril; Cardiovascular Diseases; Humans; Insulin Resistance | 1991 |
[Hyperinsulinemia. Current thinking on cardiovascular risks].
Topics: Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Risk Factors | 1990 |
[New momentum in cardiovascular therapy. Further development of ACE inhibitors: from captopril to lisinopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Humans; Lisinopril | 1988 |
[The clinical use of angiotensin converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Hypertension; Oligopeptides; Teprotide | 1986 |
[The renin-angiotensin system. Applications in pediatrics. (II)].
Topics: Adolescent; Captopril; Cardiovascular Diseases; Child; Child, Preschool; Enalapril; Endocrine System Diseases; Humans; Hypertension, Renal; Infant; Infant, Newborn; Renin-Angiotensin System | 1986 |
[Nifedipine, captopril and labetalol--overviews on the pattern of adverse effects].
Topics: Captopril; Cardiovascular Diseases; Drug Eruptions; Ethanolamines; Gastrointestinal Diseases; Humans; Labetalol; Nervous System Diseases; Nifedipine; Proline | 1985 |
Pathophysiology and outcome of hypertensive subjects.
Topics: Adult; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Catecholamines; Circadian Rhythm; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renovascular; Kidney Function Tests; Male; Middle Aged; Renin-Angiotensin System; Risk; Water-Electrolyte Balance | 1985 |